On July 27th, Evergrande Health announced on the Hong Kong Stock Exchange that the board of directors suggested changing the name of the company to "China Evergrande New Energy Automobile Group Co., Ltd." in view of the fact that new energy vehicles have become the most important business of the group? New? Energy? Vehicle? Group? Limited), referred to as "Evergrande Automobile". The board of directors believes that the proposed name change is in the overall interests of the company and its shareholders.
The change of name also requires shareholders to vote for a special resolution at the company's general meeting to approve the change of company name and the Hong Kong Companies Registry to approve the change of name. After the above conditions are met, the proposed change of name will take effect on the date when the Hong Kong Companies Registry issues a certificate of company registration to confirm that the new name has been registered.
Evergrande Health said that the Group is making every effort to develop the new energy vehicle business, and has built a whole industrial chain of new energy vehicles covering power batteries, powertrains, advanced vehicle manufacturing, automobile sales and intelligent charging. Each key link has core technologies and a global integrated research and development model. In China, Sweden, Germany, Britain, Netherlands, Austria, Italy, Japan, South Korea and other countries, the goal is to become the largest and most powerful new energy automobile group in the world within 3-5 years.
Since 20 18, Evergrande Health has supplemented the industrial chain capacity of new energy vehicles through a series of mergers and acquisitions. Among them, the acquisition of Swedish electric vehicle company NEVS is an important starting point for Evergrande to lay out its automobile industry.
201965438+1October 15, Evergrande Health announced that it had acquired the equity of NEVS 5 1%, a Swedish electric vehicle company, for US$ 930 million, and won a majority of the board seats.
20 19, 1 1 year 10, Evergrande Health further increased its capital by USD 3 billion to supplement the R&D, manufacturing and general working capital of new energy vehicles and their subsidiaries.
On June 10, 2020, Evergrande Health announced that it planned to acquire the remaining equity of Swedish NEVS, a global electric vehicle company, for US$ 379.5 million. Upon completion, NEVS will become its wholly-owned subsidiary. ?
At present, Evergrande is also developing 14 new models. According to the plan, the initial production capacity of each base is 65,438+10,000 vehicles/year, the planned total production capacity in 2-3 years is 1 10,000 vehicles/year, and the planned total production capacity in 10- 15 years is 5 million vehicles/year.
This article comes from car home, the author of the car manufacturer, and does not represent car home's position.